Iranians face soaring prices for medicine as the US blockade and sanctions hit hard
Prices for 2,000 medicines were amended in six months as inflation and currency losses deepened shortages, officials said.
- Medicine prices in Iran have surged drastically as a U.S. naval blockade and sanctions squeeze the pharmaceutical industry, creating significant hardships for patients and families seeking essential treatments.
- While Iran produces more than 80% of its medicines domestically, the industry relies heavily on imported raw materials; airstrikes damaged more than 40 pharmaceutical factories, compounding supply disruptions.
- Tablets essential for kidney dialysis patients have climbed by nearly 350% in recent months, said Tehran resident Ali Fallah, as officials amended prices for 2,000 types of medicines.
- Insurance companies owe pharmacies about $270 million, falling behind by as much as nine months on payments, while medicines are smuggled to Afghanistan, Pakistan, and Iraq where prices are higher.
- Authorities imported about 700,000 flu vaccine doses from China to address shortages, though prices have nearly doubled; part-time teacher Azita Hassanpour noted her mother's cancer treatments remain delayed.
15 Articles
15 Articles
The Economic Times
Times of IndiaIran's medicines soar in price as US blockade, sanctions squeeze pharmaceutical supplies
Medication prices in Iran have surged drastically due to US sanctions and ongoing conflict, creating significant hardships. Families are struggling to find essential medications, impacting their financial stability and well-being. Pharmaceutical imports have become increasingly difficult due to naval blockades and sanctions against airlines. The Iranian government is facing pressure to manage healthcare supplies amid concerns regarding shortages.
Iranians face soaring prices for medicine as the US blockade and sanctions hit hard – WTOP News
TEHRAN, Iran (AP) — Medication prices are soaring in Iran and some treatments have become hard to find, leaving patients and their families scrambling as a U.S. blockade and stepped-up sanctions squeeze the country’s pharmaceuticals industry. Some medicines have more than tripled in price, further squeezing Iranians’ finances seven months into the country’s war with...
The Toronto Star
Iranians face soaring prices for medicine as the US blockade and sanctions hit hard
TEHRAN, Iran (AP) — Medication prices are soaring in Iran and some treatments have become hard to find, leaving patients and their families scrambling as a U.S. blockade and stepped-up sanctions squeeze the country's pharmaceuticals industry.
Tehran: Prices of medicines in Iran are rising, and it has become difficult to find some medicines, increasing the suffering of patients and their families, as the Iranian pharmaceutical industry is affected by the US blockade of Iranian ports and the tightening of United States sanctions against Iran.
Medicine prices in Iran are rising drastically, and some therapies have become almost unaffordable, putting patients in an extremely difficult situation, while the US naval blockade and increased sanctions are putting enormous pressure on the country's pharmaceutical sector.
Coverage Details
Bias Distribution
- 50% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
